According to Ovid Therapeutics 's latest financial reports the company's current EPS (TTM) is -0,67ย โฌ. In 2022 the company made an earnings per share (EPS) of -0,74ย โฌ a decrease over its 2021 EPS that were of 1,70ย โฌ.